2024 Summer Conference | C15 - Suspecting Autoimmune Encephalitis: And Now What?
Program Materials Program Evaluations
| 01:20 PM - 01:47 PM EDT | Speaker |
Autoimmune Encephalitis Diagnosis and Misdiagnosis
Amy Kunchok, MBBS |
| 01:47 PM - 02:14 PM EDT | Speaker |
Approach to Infectious Encephalitides
Nicholas Davies, PhD, FRACP |
| 02:14 PM - 02:41 PM EDT | Speaker |
Treatment Approach in Autoimmune Encephalitis
Tammy L. Smith, MD, PhD |
| 02:41 PM - 02:48 PM EDT | Abstract |
002 - MRI Characteristics of LGI1- and CASPR2-antibody Encephalitis: Independent Discovery and Validation Cohorts
Mark J. Kelly, MBBS |
| 02:48 PM - 02:55 PM EDT | Abstract |
030 - Intrathecal Steroids: A More Targeted Approach to Central Nervous System Inflammation
Kristen Fisher, DO |
| Melissa A. Wright, MD | Dr. Wright has nothing to disclose. |
| Tammy L. Smith, MD, PhD | The institution of Dr. Smith has received research support from Alexion/AstraZeneca. Dr. Smith has received personal compensation in the range of $500-$4,999 for serving as a attendee with Euroimmun Academy for travel support only. |
| Amy Kunchok, MBBS | Dr. Kunchok has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Kunchok has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology Journal . Dr. Kunchok has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology:Open Access Journal . |
| Nicholas Davies, PhD, FRACP | An immediate family member of Nicholas Davies has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sirtex Medical. An immediate family member of Nicholas Davies has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Angiodynamics. Nicholas Davies has a non-compensated relationship as a Chair of Scientific Advisory Panel with Encephalitis International (UK-based non-profit) that is relevant to AAN interests or activities. |
| Sean J. Pittock, MD, FAAN | Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arialys Therapeutics. The institution of Dr. Pittock has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Arialys. The institution of Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. The institution of Dr. Pittock has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. The institution of Dr. Pittock has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion/AstraZeneka. The institution of Dr. Pittock has received research support from NIH. The institution of Dr. Pittock has received research support from Alexion/AstraZeneka. The institution of Dr. Pittock has received research support from F. Hoffman/LaRoche/Genentech. Dr. Pittock has received intellectual property interests from a discovery or technology relating to health care. Dr. Pittock has received intellectual property interests from a discovery or technology relating to health care. Dr. Pittock has received publishing royalties from a publication relating to health care. |
| Mark J. Kelly, MBBS | The institution of Dr. Kelly has received research support from The Health Research Board / Wellcome Trust. |
| Eleanor Grant | No disclosure on file |
| Andrew Murchison | No disclosure on file |
| Sophie Binks, MD, MBBS, PhD | The institution of Ms. Binks has received research support from Wellcome Trust. The institution of Ms. Binks has received research support from PetSavers. The institution of Ms. Binks has received research support from PetPlan. The institution of Ms. Binks has received research support from NIHR. Ms. Binks has received intellectual property interests from a discovery or technology relating to health care. Ms. Binks has received personal compensation in the range of $0-$499 for serving as a Speaker with ECTRIMS. Ms. Binks has received personal compensation in the range of $0-$499 for serving as a Speaker with Vetmeduni Wien. Ms. Binks has received personal compensation in the range of $0-$499 for serving as a Speaker with ANA. Ms. Binks has a non-compensated relationship as a Speaker with Encephalitis Society UK that is relevant to AAN interests or activities. |
| Sudarshini Ramanathan, MBBS, PhD, FRACP | Dr. Ramanathan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Ramanathan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen, Alexion, Novartis. Dr. Ramanathan has received research support from NHMRC, RACP, University of Sydney. |
| Sophia Michael, PhD, MBChB; DPhil (Oxon) | Dr. Michael has nothing to disclose. |
| Adam Handel | No disclosure on file |
| Lahiru Handunnetthi, MBBS | The institution of Dr. Handunnetthi has received research support from Janssen Pharmaceuticals. |
| Christopher E. Uy, MD | Dr. Uy has nothing to disclose. |
| Fintan Sheerin | No disclosure on file |
| Eoin P. Flanagan, MBBCh, FAAN | The institution of Dr. Flanagan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Flanagan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Flanagan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon Therapeutics. The institution of Dr. Flanagan has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Flanagan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Pharmacy times. The institution of Dr. Flanagan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB. The institution of Dr. Flanagan has received research support from Viela Bio. The institution of Dr. Flanagan has received research support from UCB. The institution of Dr. Flanagan has received research support from Roche. Dr. Flanagan has received publishing royalties from a publication relating to health care. Dr. Flanagan has a non-compensated relationship as a Member of medical Advisory Board with The MOG Project that is relevant to AAN interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial board member with Journal of The Neurologic Sciences that is relevant to AAN interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial board member with Neuroimmunology Reports that is relevant to AAN interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial Board Member with Neurology, Neuroimmunology Neuroinflammation (N2) Journal that is relevant to AAN interests or activities. |
| Gregory S. Day, MD, MSc, FAAN | Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Parabon Nanolabs. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arialys Therapeutics. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vigil Neuro. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for DynaMed (EBSCO Health). Dr. Day has stock in ANI Pharmaceuticals. The institution of Dr. Day has received research support from National Institutes of Health / NIA. The institution of Dr. Day has received research support from Chan Zuckerberg Initiative. The institution of Dr. Day has received research support from Alzheimer's Association. The institution of Dr. Day has received research support from National Institutes of Health / NINDS. The institution of Dr. Day has received research support from Amgen Pharmaceuticals. The institution of Dr. Day has received research support from AVID Radiopharmaceuticals. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Presenter at Annual Meeting (CME) with 好色先生. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Content Development (CME) with PeerView, Inc. Dr. Day has received personal compensation in the range of $5,000-$9,999 for serving as a Content Development (CME) with Continuing 好色先生, Inc. Dr. Day has received personal compensation in the range of $5,000-$9,999 for serving as a Content Development (CME) with Ionis Pharmaceuticals. Dr. Day has a non-compensated relationship as a Clinical Director with Anti-NMDA Receptor Encephalitis Foundation that is relevant to AAN interests or activities. |
| Alfonso S. Lopez, MD | Dr. Lopez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Lopez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech . |
| Divyanshu Dubey, MD, FAAN | The institution of Dr. Dubey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. The institution of Dr. Dubey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arialys. The institution of Dr. Dubey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB . Dr. Dubey has received research support from Department of Defense . Dr. Dubey has received research support from Department of Defense . Dr. Dubey has received research support from UCB. Dr. Dubey has received research support from David J. Tomassoni ALS Research Grant Program . Dr. Dubey has received intellectual property interests from a discovery or technology relating to health care. Dr. Dubey has received intellectual property interests from a discovery or technology relating to health care. Dr. Dubey has received intellectual property interests from a discovery or technology relating to health care. Dr. Dubey has received intellectual property interests from a discovery or technology relating to health care. |
| John N. Soltys, MD | Dr. Soltys has nothing to disclose. |
| Sarosh R. Irani, MD, PhD, FRCP, FEAN | Dr. Irani has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for UCB, Immunovant, MedImmun, Roche, Janssen, Cerebral therapeutics, Biogen, Amgen, Argenex, Clarivate, IQVIA, BioHaven therapeutics, ADC therapeutics, Brain, CSL Behring, and ONO Pharma.. Dr. Irani has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Irani has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Irani has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Brain. Dr. Irani has received personal compensation in the range of $100,000-$499,999 for serving as an Expert Witness for LLPs. Dr. Irani has received intellectual property interests from a discovery or technology relating to health care. Dr. Irani has received intellectual property interests from a discovery or technology relating to health care. Dr. Irani has received intellectual property interests from a discovery or technology relating to health care. |
| Mitsuyuki Matsumoto, PhD | Dr. Matsumoto has received personal compensation for serving as an employee of Arialys Therapeutics, Inc.. Dr. Matsumoto has received personal compensation in the range of $100,000-$499,999 for serving as an officer or member of the Board of Directors for Arialys Therapeutics, Inc.. Dr. Matsumoto has stock in Arialys Therapeutics, Inc.. Dr. Matsumoto has received intellectual property interests from a discovery or technology relating to health care. |
| Masashi Maeda | No disclosure on file |
| Atsuo Kanno | No disclosure on file |
| Satoshi Kubo | No disclosure on file |
| Amir Razai | Amir Razai has received personal compensation for serving as an employee of Arialys . |
| Shanni Yamaki | Shanni Yamaki has received personal compensation for serving as an employee of Arialys Therapeutics Inc. . |
| Roghiye Kazimi | Roghiye Kazimi has nothing to disclose. |
| Vallari Eastman | Vallari Eastman has nothing to disclose. |
| Mari Maurer | Ms. Maurer has received personal compensation for serving as an employee of Arialys Therapeuticss, Inc.. Ms. Maurer has received personal compensation for serving as an employee of ESCAPE Bio. Ms. Maurer has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for ReCode Therapeutics. Ms. Maurer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Momentum Pharma. Ms. Maurer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for ESCAPE Bio. Ms. Maurer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Arialys Therapeutics. |
| Mathew Mitchell | Mr. Mitchell has received personal compensation for serving as an employee of Arialys Therapeutics. |
| Jay Lichter, PhD | Dr. Lichter has received personal compensation in the range of $50,000-$99,999 for serving as an officer or member of the Board of Directors for Janux. |
| Scott Snipas | Scott Snipas has received personal compensation for serving as an employee of Arialys Therapeutics . |
| Jon A. Cokley, PharmD | An immediate family member of Dr. Cokley has received personal compensation for serving as an employee of Johnson and Johnson Vision. Dr. Cokley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Xenon Pharmaceuticals. Dr. Cokley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Wolters Kluwer. Dr. Cokley has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB Pharmaceuticals. Dr. Cokley has received publishing royalties from a publication relating to health care. Dr. Cokley has a non-compensated relationship as a Board of Trustees with Neurocricitical Care Foundation that is relevant to AAN interests or activities. |
| Kristen Fisher, DO | Dr. Fisher has nothing to disclose. |